Zyla Life Sciences (FKA Egalet Corporation)
Registrant's name change from Egalet Corporation to Zyla Life Sciences
Based in PA
AI Overview
With $515K in lobbying spend across 9 quarterly filings, Zyla Life Sciences (FKA Egalet Corporation) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $515K |
| 2019 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Zyla Life Sciences (FKA Egalet Corporation) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Alcohol & Drug Abuse
Prescription drug abuse policy issues
Provisions related to abuse-deterrent opioid formulary placement
Provisions related to abuse-deterrent opioid coverage and access in Medicare
Prescription drug abuse and misuse policy issues
H.R. 2335 (114th Congress), the Stop Tampering of Prescription Pills Act: provisions related to approval of abuse-deterrent opioids
H.R. 5127 (114th Co
S. 524 (114th Congress): Provisions related to opioid treatment and abuse
Prescription drug abuse policy issues
Provisions related to abuse-deterrent opioid formulary placement
Provisions related to abuse-deterrent opioid coverage and access in Medicare
H.R. 5582, the Abuse
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.